Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia
- 1 July 2002
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 16 (7) , 1302-1310
- https://doi.org/10.1038/sj.leu.2402534
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 49 references indexed in Scilit:
- Angiogenesis in acute and chronic leukemias and myelodysplastic syndromesBlood, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemiaLeukemia, 2000
- Increased angiogenesis in the bone marrow of patients with acute myeloid leukemiaBlood, 2000
- New agents for acute myelogenous leukemiaLeukemia, 2000
- Evidence of increased angiogenesis in patients with acute myeloid leukemiaBlood, 2000
- Angiogenesis in myelodysplastic syndromesBritish Journal of Cancer, 1999
- Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myelomaLeukemia, 1999
- Blood Vessel Formation: What Is Its Molecular Basis?Cell, 1996
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994